These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 12846581)
1. Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment. Berry RW; Abraha A; Lagalwar S; LaPointe N; Gamblin TC; Cryns VL; Binder LI Biochemistry; 2003 Jul; 42(27):8325-31. PubMed ID: 12846581 [TBL] [Abstract][Full Text] [Related]
2. Tau polymerization: role of the amino terminus. Gamblin TC; Berry RW; Binder LI Biochemistry; 2003 Feb; 42(7):2252-7. PubMed ID: 12590615 [TBL] [Abstract][Full Text] [Related]
3. Protein anatomy: C-tail region of human tau protein as a crucial structural element in Alzheimer's paired helical filament formation in vitro. Yanagawa H; Chung SH; Ogawa Y; Sato K; Shibata-Seki T; Masai J; Ishiguro K Biochemistry; 1998 Feb; 37(7):1979-88. PubMed ID: 9485325 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylation modulates the local conformation and self-aggregation ability of a peptide from the fourth tau microtubule-binding repeat. Du JT; Yu CH; Zhou LX; Wu WH; Lei P; Li Y; Zhao YF; Nakanishi H; Li YM FEBS J; 2007 Oct; 274(19):5012-20. PubMed ID: 17725643 [TBL] [Abstract][Full Text] [Related]
5. Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR. Ma QF; Li YM; Du JT; Kanazawa K; Nemoto T; Nakanishi H; Zhao YF Biopolymers; 2005 Oct; 79(2):74-85. PubMed ID: 15986501 [TBL] [Abstract][Full Text] [Related]
6. Proapoptotic effects of tau cleavage product generated by caspase-3. Chung CW; Song YH; Kim IK; Yoon WJ; Ryu BR; Jo DG; Woo HN; Kwon YK; Kim HH; Gwag BJ; Mook-Jung IH; Jung YK Neurobiol Dis; 2001 Feb; 8(1):162-72. PubMed ID: 11162250 [TBL] [Abstract][Full Text] [Related]
7. Conformational transition state is responsible for assembly of microtubule-binding domain of tau protein. Hiraoka S; Yao TM; Minoura K; Tomoo K; Sumida M; Taniguchi T; Ishida T Biochem Biophys Res Commun; 2004 Mar; 315(3):659-63. PubMed ID: 14975751 [TBL] [Abstract][Full Text] [Related]
8. Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy. Sibille N; Sillen A; Leroy A; Wieruszeski JM; Mulloy B; Landrieu I; Lippens G Biochemistry; 2006 Oct; 45(41):12560-72. PubMed ID: 17029411 [TBL] [Abstract][Full Text] [Related]
9. The solution structure of the C-terminal segment of tau protein. Esposito G; Viglino P; Novak M; Cattaneo A J Pept Sci; 2000 Nov; 6(11):550-9. PubMed ID: 11147714 [TBL] [Abstract][Full Text] [Related]
10. The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis. von Bergen M; Barghorn S; Müller SA; Pickhardt M; Biernat J; Mandelkow EM; Davies P; Aebi U; Mandelkow E Biochemistry; 2006 May; 45(20):6446-57. PubMed ID: 16700555 [TBL] [Abstract][Full Text] [Related]
11. Mercury(II) promotes the in vitro aggregation of tau fragment corresponding to the second repeat of microtubule-binding domain: Coordination and conformational transition. Yang DJ; Shi S; Zheng LF; Yao TM; Ji LN Biopolymers; 2010 Dec; 93(12):1100-7. PubMed ID: 20665688 [TBL] [Abstract][Full Text] [Related]
12. A complex mechanism for inducer mediated tau polymerization. Carlson SW; Branden M; Voss K; Sun Q; Rankin CA; Gamblin TC Biochemistry; 2007 Jul; 46(30):8838-49. PubMed ID: 17608454 [TBL] [Abstract][Full Text] [Related]
13. Ser Sandhu P; Naeem MM; Lu C; Kumarathasan P; Gomes J; Basak A Bioorg Med Chem Lett; 2017 Feb; 27(3):642-652. PubMed ID: 27989667 [TBL] [Abstract][Full Text] [Related]
14. Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS. Ma Q; Li Y; Du J; Liu H; Kanazawa K; Nemoto T; Nakanishi H; Zhao Y Peptides; 2006 Apr; 27(4):841-9. PubMed ID: 16225961 [TBL] [Abstract][Full Text] [Related]
15. Tau induces ring and microtubule formation from alphabeta-tubulin dimers under nonassembly conditions. Devred F; Barbier P; Douillard S; Monasterio O; Andreu JM; Peyrot V Biochemistry; 2004 Aug; 43(32):10520-31. PubMed ID: 15301550 [TBL] [Abstract][Full Text] [Related]
16. Characterization of two VQIXXK motifs for tau fibrillization in vitro. Li W; Lee VM Biochemistry; 2006 Dec; 45(51):15692-701. PubMed ID: 17176091 [TBL] [Abstract][Full Text] [Related]
17. X-ray structure of the PHF core C-terminus: insight into the folding of the intrinsically disordered protein tau in Alzheimer's disease. Sevcik J; Skrabana R; Dvorsky R; Csokova N; Iqbal K; Novak M FEBS Lett; 2007 Dec; 581(30):5872-8. PubMed ID: 18061582 [TBL] [Abstract][Full Text] [Related]
18. O-GlcNAcylation modulates the self-aggregation ability of the fourth microtubule-binding repeat of tau. Yu CH; Si T; Wu WH; Hu J; Du JT; Zhao YF; Li YM Biochem Biophys Res Commun; 2008 Oct; 375(1):59-62. PubMed ID: 18671940 [TBL] [Abstract][Full Text] [Related]
19. Role of cysteine-291 and cysteine-322 in the polymerization of human tau into Alzheimer-like filaments. Bhattacharya K; Rank KB; Evans DB; Sharma SK Biochem Biophys Res Commun; 2001 Jul; 285(1):20-6. PubMed ID: 11437366 [TBL] [Abstract][Full Text] [Related]
20. The self-assembly ability of the first microtubule-binding repeat from tau and its modulation by phosphorylation. Zhou LX; Zeng ZY; Du JT; Zhao YF; Li YM Biochem Biophys Res Commun; 2006 Sep; 348(2):637-42. PubMed ID: 16889747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]